6505--Blueprint Medicines, Corporation (PENDING PROPOSAL)

Blueprint Medicines Corporation has been awarded a contract under Solicitation Number 36F79726D0119 by the Department of Veterans Affairs through its Federal Supply Schedule program, with an estimated value of $394,061,600. The contract, effective from May 15, 2026, through May 14, 2031, is classified as a Total Small Business Set-Aside under FAR 19.5, confirming the awardee’s self-certified status as a small business for NAICS code 325412, which pertains to pharmaceutical preparation manufacturing. The primary place of performance is designated as Hines, Illinois, at the VA’s OPAL/National Acquisition Center, while the company’s headquarters is located in Cambridge, Massachusetts. The products delivered under this contract fall under Product Service Code 6505, indicating the supply of pharmaceuticals and biologicals, though no detailed specifications, quantities, or delivery schedules are disclosed. The contracting office for administrative oversight is the VA Federal Supply Schedule team, reachable via the FSS Help Desk, and no specific contracting officer, COR, or COTR is identified in the available data. The contract does not include publicly accessible details on evaluation factors, special requirements, packaging standards, inspection procedures, invoicing methods, or attachment lists, and no clause text, pricing line items, or option periods are provided. The awardee’s Unique Entity Identifier is W42KVS8X5BV9, but its CAGE code is not listed, and no additional socioeconomic certifications beyond small business status are indicated. Compliance with FAR 19.5 entails ongoing verification of small business eligibility and potential reporting obligations, though no Recovery Act or labor standards triggers apply. All administrative inquiries should be directed to the provided contact information.